Primary testicular lymphoma: The site matters

Leukemia and Lymphoma

Volumn 51, Issue 7, 2010, Pages 1159-1160

  Stefanovic, Alexandra ^a   Lossos, Izidore S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; LACTATE DEHYDROGENASE; METHOTREXATE; RITUXIMAB;

CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; NOTE; ORCHIECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TESTICULAR LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TESTIS TUMOR; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 77954104915     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.481067     Document Type: Note

References (11)

1. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
2. Mazloom A, Fowler N, Medeiros J, Iyengar P, Horace P, Dabaja B. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma 2010;51:1217-1224.
3. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003;21:20-27.
4. Connors JM, Klimo P, Voss N, Fairey RN, Jackson S. Testicular lymphoma: improved outcome with early brief chemotherapy. J Clin Oncol 1988;6:776-781.
5. Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994;30A:1760-1764.
6. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000;88:154-161. (Pubitemid 30027691)
7. Lagrange JL, Ramaioli A, Theodore CH, et al. Non- Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol 2001;12:1313-1319.
8. Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol 1995;13:1361-1367.
9. Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 2009;27:5227-5232.
10. Hasselblom S, Ridell B, Wedel H, Norrby K, Sender Baum M, Ekman T. Testicular lymphoma-a retrospective, population- based, clinical and immunohistochemical study. Acta Oncol 2004;43:758-765.
11. Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases. Mod Pathol 2006;19:1521-1527.